Related Experiment Video
Updated: Feb 24, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Improvements in Albuminuria Screening Among Individuals with Hypertension Associated with Electronic Health Record
Insights
Clinical decision support strategies significantly increased albuminuria testing in hypertension patients. These electronic health record tools improved early detection and risk stratification for cardiovascular disease and chronic kidney disease.
Area of Science:
- Nephrology
- Cardiology
- Health Informatics
Background:
- Albuminuria is a key risk factor for cardiovascular disease (CVD), heart failure, and chronic kidney disease (CKD) progression.
- Early detection via urine albumin creatinine ratio (UACR) testing aids risk stratification and preventative therapy.
- UACR testing rates remain low in the hypertension population.
Purpose of the Study:
- To evaluate the effectiveness of two electronic health record (EHR)-embedded clinical decision support (CDS) strategies in increasing UACR testing rates among hypertensive patients.
- To compare UACR testing trends in a health system implementing CDS with control health systems.
Main Methods:
- Two EHR-embedded CDS strategies were implemented at Geisinger Health System: an OurPractice Advisory (OPA) and a Health Maintenance Topic (HMT).
- UACR testing rates from 2020-2023 in Geisinger primary care were compared to a control group from the Optum Labs Data Warehouse (OLDW).
- Patients with prior UACR testing, diabetes, CKD, or palliative care were excluded.
Main Results:
- Geisinger's UACR testing rates increased from 2.97% in 2020 to 17.5% in 2023, significantly outpacing control systems (2.08% to 3.40%).
- The OPA strategy approximately tripled UACR testing rates.
- The subsequent HMT strategy further enhanced testing, achieving approximately a six-fold increase from baseline.
Conclusions:
- EHR-embedded CDS strategies, particularly the HMT, can substantially improve UACR testing rates in hypertensive patients.
- Effective CDS design plays a crucial role in closing care gaps for albuminuria detection.
- Increased UACR testing facilitates better risk management for cardiovascular and kidney diseases.
Background:
Albuminuria is associated with increased risk of cardiovascular disease (CVD), heart failure, and progression of chronic kidney disease (CKD). Early detection of albuminuria, done through spot urine albumin creatinine ratio (UACR) testing, enables more accurate risk stratification and timely use of preventative therapies. It remains unacceptably low in the hypertension population.
Methods:
We evaluated two EHR-embedded clinical decision support (CDS) strategies at Geisinger Health System in order to increase UACR testing in individuals with hypertension: an OurPractice Advisory (OPA) from Jan 2022 to Aug 2022; and a Health Maintenance Topic (HMT) in the Care Gaps section of Storyboard from Aug 2022 that continues to date. We evaluated UACR rates from 2020 to 2023 in Geisinger primary care and compared to a control group of healthcare systems in the Optum Labs Data Warehouse [OLDW]. Patients were excluded if they had UACR testing in the preceding 3 years, had diabetes or CKD, or were receiving palliative/hospice care.
Results:
We included 58,876 individuals in Geisinger (mean age 59.4 years, 49.6% female) and 1,427,754 in OLDW (61.0 years, 49% female). UACR testing in Geisinger (2.97% in 2020; 2.8% in 2021; 9.7% in 2022; 17.5% in 2023) showed significant increase compared to the control health systems (2.08%, 2.26%, 3.35% and 3.40% respectively). Results were consistent after adjusting for age, sex and race.
Conclusion:
OPA increased UACR testing ∼3-fold whereas the HMT was associated with further improvements (∼6-fold vs. baseline) among those with hypertension, suggesting an important role for CDS design in closing care gaps.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Chronic Kidney Disease III: Interprofessional Care
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hypertension V: Nursing Management

